Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_assertion type Assertion NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_head.
- NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_assertion description "[CHRNA3 (rs1051730) genotyping can improve customized chemotherapy based on tumor assessment of ERCC1 mRNA in stage IV NSCLC with PS 0.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_provenance.
- NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_assertion evidence source_evidence_literature NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_provenance.
- NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_assertion SIO_000772 19733931 NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_provenance.
- NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_assertion wasDerivedFrom befree-20140225 NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_provenance.
- NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_assertion wasGeneratedBy ECO_0000203 NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_provenance.